Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

Tag Archives: disease

My Residency, My Experience, A Foundation for My Career...
February 1, 2012 - Professional Advice / Opinions

By: Sum Lam, PharmD, CGP, BCPS, FASCP – Sum Lam, Pharm.D., CGP, BCPS, FASCP is an Associate Clinical Professor in the Department of Clinical Pharmacy Practice at St. John’s University College of Pharmacy and Allied Health Professions.  In conjunction with her full time appointment at St. John’s University, she is a clinical faculty at Geriatric…

The Importance of Researching Residency Sites...
February 1, 2012 - Professional Advice / Opinions

By: Dr. Regina Ginzburg – Regina Ginzburg is an Associate Clinical Professor of St. John’s University College of Pharmacy and Allied Health Professions. Her clinical site is at the Institute for Family Health (IFH) where she is an appointed faculty member for the Beth Israel Residency in Urban Family Health. She and Dr. See oversee…

Express, Be Involved, and Grow...
February 1, 2012 - Professional Advice / Opinions

By: Dr. Gregory J. Hughes – Gregory J. Hughes, PharmD, BCPS, CGP is an Assistant Clinical Professor in the Clinical Pharmacy Practice department at St. John’s University College of Pharmacy and Allied Health Professions.  He completed his pharmacy practice residency at the St. Louis VA Medical Center and the St. Louis College of Pharmacy with…

Hope on the Horizon: Chikungunya Vaccine Trial Begins!...
January 1, 2012 - Clinical , Featured , In the News / Politics

By: Ebey P. Soman – Since its discovery in Tanganyika (modern day Mozambique and Tanzania in Africa) in 1952, Chikungunya virus outbreaks have been documented in Africa, South Asia, and Southeast Asia.  Due to recent globalization and increased travel, infection has also spread outside of tropical regions and even into western nations (such as the…

FDA Approves Edarbyclor®...
January 1, 2012 - Clinical , In the News / Politics

By: Gokul Kalla, Pharm.D. Candidate c/o 2013 – Hypertension is a chronic disease that affects one out of every three Americans.  Leaving the condition untreated could increase the risk of serious health consequences such as a stroke or a heart attack.  On December 21, the FDA approved Takeda Pharmaceuticals’ Edarbyclor® (azilsartan medoxomil and chlorthalidone) for…

Xigris: A Worldwide Withdrawal...
January 1, 2012 - Clinical , In the News / Politics

By: Khilna Patel, Pharm.D. Candidate c/o 2012 – On October 25 of this year, Eli Lilly and Company announced a worldwide market withdrawal of Xigris (drotrecogin alfa), a drug previously indicated to treat severe sepsis in high-risk patients.  Drotrecogin alfa is a recombinant form of human activated protein C.  The efficacy of drotrecogin alfa was…

A Day in the Life of a Cardiac Care Unit Pharmacist...
December 1, 2011 - Professional Advice / Opinions

By: Dr. Manouchkathe Cassagnol – Dr. Manouchkathe Cassagnol is an Assistant Clinical Professor at St. John’s University College of Pharmacy and Allied Health Professions and a Clinical Coordinator of Internal Medicine and Cardiology Pharmacotherapy at Long Island Jewish Medical Center. About 81 million people in this country suffer from cardiovascular disease. Therefore, as pharmacy practitioners,…

Differences Between Antagonists and Inverse Agonists...
December 1, 2011 - Clinical

By: Neal Shah – There are two major classifications of drug-receptor activity: agonism and antagonism. Agonism occurs when a molecule binds to a receptor, causes an exertion of normal receptor operation, and eventually causes a response. Antagonism of a receptor occurs when a molecule binds to the receptor and does not allow activity to occur.1…

Ivabradine: A Novel I(f) Blocker for Stable Angina...
December 1, 2011 - Clinical

By: Neal Shah – Part I:              Preface. Part II:             Brief review of cardiac electrophysiology. Part III:           Ivabradine as a novel If blocker for the use of stable angina. Part IV:           On the horizon: trimetazidine. – PREFACE When viewed anatomically, the heart may seem like a simple organ.  However, the electrophysiological aspects of the heart are…

Finding Your Niche in Pharmacy...
December 1, 2011 - Professional Advice / Opinions

By: Nandini Puranprashad – As primary advocators of patient care, student pharmacists and pharmacists are well on their way in changing the public’s impression of us staying behind the counter at the corner drugstore doing nothing but “counting, licking, and sticking.” It is time to step out of the classroom and from behind the counters…

Interview with Dr. Elizabeth Palillo...
December 1, 2011 - Featured , Professional Advice / Opinions

By: Mahdieh Danesh Yazdi – Dr. Elizabeth Palillo graduated from the University of Connecticut in 2006. She then worked as a manager at CVS for a year and a half, and eventually moved to New York, where she worked at two other CVS stores. Dr. Palillo then left CVS and joined Bronx-Lebanon Hospital as a…

HIV Transmitted from a Living Organ Donor: NYC, 2009...
December 1, 2011 - Clinical

By: Alisha Kumar, PharmD Candidate c/o 2012 – HIV transmission via organ transplantation is rare in the United States. However, after a public health investigation in 2010, a case of HIV transmission via kidney transplantation was confirmed. The kidney recipient had no history of sexually transmitted infections (STIs), injection drug use, sex with injection drug…

Faculty Spotlight: Dr. Charles R. Ashby...
December 1, 2011 - Featured , Professional Advice / Opinions

By: Neal Shah – Dr. Ashby is a well-known Pharmacology professor for student pharmacists studying in their professional years. He graduated from the University of Louisville with a BA in Biology and Psychology in 1983. After obtaining his PhD in Pharmacology from the University of Louisville in 1987, he continued his education by obtaining a…

Federal Government to Attempt Limiting Drug Shortages...
December 1, 2011 - In the News / Politics

By: Mahdieh Danesh Yazdi, with special thanks to Dr. Tomasz Jodlowski – Drug shortages have plagued health care institutions in recent years; they present a serious problem to health care delivery on a national scale. In 2004, there were 58 drug shortages; now, in 2011, this number has increased to 198. Due to limited access…

Pharmacogenetic Applications in Clinical Practice...
November 1, 2011 - Clinical , Featured

By: Neal Shah – The focus of pharmacy is rapidly shifting from simple filling and dispensing of prescriptions to preventative medicine and efficient clinical practice. The field of genetics has been incorporated in many defining therapies and will continue to shape how we treat our patients. Examples discussed here are the roles of human leukocyte…

Fluzone High-Dose Influenza Vaccine...
November 1, 2011 - Clinical

By; Nikunj Vyas, PharmD Candidate c/o 2012 – Seasonal flu vaccines protect us against the three influenza viruses that researchers predict will be the most common viral strains during the flu season. The viruses in the vaccine change each year based on international surveillance and scientists‘ estimations about the types and strains of viruses that…

In The News: TNF-Alpha Inhibitors Receive More Warnings...
October 1, 2011 - In the News / Politics

By Ebey P. Soman – TNF-alpha inhibitors are drugs used to treat rheumatoid arthritis, Crohn’s disease, and ulcerative colitis, as well as other disease states. These agents suppress the immune system and increase the risk of developing serious infections. Currently, there are five approved drugs in this category: • Adalimumab (Humira®, Abbott) • Certolizumab pegol…

Faculty Spotlight: Dr. Parnali Chatterjee...
October 1, 2011 - Featured , Professional Advice / Opinions

By: Ebey P. Soman – Meet Dr. Parnali Chatterjee, a new faculty member in our St. John’s University family. I had the opportunity to meet Dr. Chatterjee at the doctoral seminar hosted by Dr. Lin Mantell entitled, “Drug Metabolism and Pharmacokinetics in Drug Discovery and Development.” I was introduced to Dr. Chatterjee through Dr. Frank…

Post navigation

Newer posts →


Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post